Insmed | INSM - Zobowiązania





Zobowiązania Zmiana Data
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cytokinetics USD 202.45M 60.31M 2025-12
DBV Technologies USD 49.48M 60K 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Novartis USD 32B 286M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12